Human PARP1/ADPRT/ADPRT 1 ORF/cDNA clone-Adenovirus particle (NM_001618.3)
Cat. No.: vGMAD000125
Pre-made Human PARP1/ADPRT/ADPRT 1 Adenovirus for PARP1 overexpression in-vitro and in-vivo. The PARP1 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified PARP1-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
PARP1/ADPRT products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
vGMAD000125 | Human PARP1 Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
5E+10PFU (1E+10pfu/ml×5ml) | |||
1E+11PFU (1E+10pfu/ml×10ml) | |||
Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
GMP-like Grade | inquiry | ||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMAD000125 |
Gene Name | PARP1 |
Accession Number | NM_001618.3 |
Gene ID | 142 |
Species | Human |
Product Type | Adenovirus particle (overexpression) |
Insert Length | 3045 bp |
Gene Alias | ADPRT,ADPRT 1,ADPRT1,ARTD1,pADPRT-1,PARP,PARP-1,PPOL |
Fluorescent Reporter | Null |
Mammalian Cell Selection | Null |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-T06273-Ab | Anti-PARP1 monoclonal antibody |
Target Antigen | GM-Tg-g-T06273-Ag | PARP1 protein |
ORF Viral Vector | pGMLV002255 | Human PARP1 Lentivirus plasmid |
ORF Viral Vector | pGMAD000125 | Human PARP1 Adenovirus plasmid |
ORF Viral Vector | pGMPC001282 | Human PARP1 Mammalian (Non-Viral Vector) plasmid |
ORF Viral Vector | vGMLV002255 | Human PARP1 Lentivirus particle |
ORF Viral Vector | vGMAD000125 | Human PARP1 Adenovirus particle |
Target information
Target ID | GM-T06273 |
Target Name | PARP1 |
Gene ID | 142, 11545, 698806, 25591, 101081434, 490385, 286764, 100058523 |
Gene Symbol and Synonyms | 5830444G22Rik,Adprp,ADPRT,ADPRT 1,ADPRT1,ARTD1,msPARP,pADPRT-1,PARP,PARP-1,PARP1,PARS,Poly-PARP,PPOL,sPARP-1 |
Uniprot Accession | P09874 |
Uniprot Entry Name | PARP1_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | Cancer |
Gene Ensembl | ENSG00000143799 |
Target Classification | Tumor-associated antigen (TAA) |
This gene encodes a chromatin-associated enzyme, poly(ADP-ribosyl)transferase, which modifies various nuclear proteins by poly(ADP-ribosyl)ation. The modification is dependent on DNA and is involved in the regulation of various important cellular processes such as differentiation, proliferation, and tumor transformation and also in the regulation of the molecular events involved in the recovery of cell from DNA damage. In addition, this enzyme may be the site of mutation in Fanconi anemia, and may participate in the pathophysiology of type I diabetes. [provided by RefSeq, Jul 2008]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.